Table 5.

Patients referred to another organ-specific cancer patient pathway (CPP) among the study population during LCPP and within 10 days after the LCPP

	Patientsa n (%)
Total	1,391 (100)
Colorectal CPP	252 (18.1)
Head and neck CPP	216 (15.5)
Urinary CPP	141 (10.1)
Non-specific symptoms and signs of cancer CPP	139 (10.0)
Breast CPP	131 (9.4)
Gastrointestinal CPP	109 (7.8)
Lymphatic and leukaemia CPP	66 (4.7)
Prostate CPP	53 (3.8)
Metastasis with unknown primary tumor CPP	53 (3.8)
Pleura CPP	38 (2.7)
Ovarian CPP	38 (2.7)
Pancreas CPP	38 (2.7)
Myeloma CPP	24 (1.7)
Uterus CPP	19 (1.4)
Melanoma CPP	15 (1.1)
Other CPPsb	59 (4.2)

^aIn cases where patients are referred to more than one CPP, the first CPP after LCPP is included.

^bCPPs including <15 patients.